Skip to main content

Advertisement

Table 1 Baseline demographic and clinical characteristics of the cohort studied (N = 330 patients).

From: Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting

Characteristic Not failed (n = 151) Failed (n = 179) P-value
Gender    
   Male 84(56) 93(52) 0.51
   Female 67(44) 86(48)  
Age [median years(IQR)] 34(29–40) 32(27–38) 0.15
Socioeconomic status    
   High status 68(45) 88(49) 0.45
   Low status 83(55) 91(51)  
Baseline CD4 cell count (cells/μl)    
   Median (IQR) 331(193–467) 323(208–431) 0.74
   < 200 40(27) 38(21) 0.28
   200–350 41(27) 62(35)  
   > 350 70(46) 79(44)  
WHO stage    
   Stage 1&2 74(49) 83(46) 0.82
   Stage 3 59(39) 71(40)  
   Stage 4 18(12) 25(14)